Artia Global Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Artia Global Partners’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-51,714	Closed	-$2.05M	–	59
2024 Q1	$2.05M	Buy	+51,714	New	+$1.53M	0.41%	27

Artia Global Partners's ALPN Position: Q2 2024 in Review

Artia Global Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 51,714 shares — an estimated $2.05M sold.

Artia Global Partners first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $2.05M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Artia Global Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Artia Global Partners sold 51,714 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.05M.
Artia Global Partners first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Artia Global Partners's Alpine Immune Sciences Inc position peaked at $2.05M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Artia Global Partners's 13F filing for Q2 2024, filed 14 Aug 2024.